BioLab Holdings, Inc. Unveils Advanced Amniotic Skin Substitute
BioLab Holdings, Inc. Unveils Advanced Amniotic Skin Substitute
Tri-Membrane Wrap Developed to Protect Deep Wounds in Difficult-to-Cover Areas
BioLab Holdings, Inc.'s skin substitute brand, BioLab Sciences, has just introduced an innovative amniotic membrane tissue product called the Tri-Membrane Wrap. This product is specifically designed to enhance wound healing capabilities for patients with complex needs. As a Phoenix-based medical manufacturer specializing in wound care, BioLab strives to be at the forefront of developments in skin substitute technology.
Features of the Tri-Membrane Wrap
The Tri-Membrane Wrap showcases an impressive triple-layer structure composed of dehydrated Amnion-Chorion-Amnion tissue, significantly increasing its thickness and tensile strength. This unique design is advantageous, enabling suturing where necessary, making it suitable for deep wounds and those located in hard-to-reach areas. Offering an alternative to existing skin substitutes, this wrap allows for a wound VAC system to be effectively utilized, providing maximum coverage for larger wounds. The product is available in sizes that range from 4 square centimeters to an impressive 480 square centimeters.
Clinician Commitment
Chief Medical Officer, Dr. Marshall Medley, expressed enthusiasm about this latest addition, stating, "This is the fourth product added to our family of amniotic products. Part of our mission is to provide clinicians with more wound care options, empowering them to select the appropriate product based on their patients' distinctive needs. We continue to bring innovative skin substitutes into the field, assisting providers with challenging wounds." This reflects BioLab's commitment to provide effective solutions in the specialized field of wound care.
Regulatory and Accessibility
The Tri-Membrane Wrap meets stringent standards and is Tissue Reference Group (TRG) registered with the FDA. It has been assigned a dedicated HCPCS code, Q4334, and will be accessible through prominent Medicare Administrative Contractor jurisdictions, namely FCSO, NOVITAS, and CGS. This ensures that healthcare providers can confidently use this product to support their patients' recovery.
Comprehensive Provider Support
Beyond offering high-quality wound care products, BioLab is dedicated to providing an extensive suite of services to assist healthcare providers. Before introducing its products to new providers, BioLab offers training on product protocols, guidance on timelines, insurance verifications, and billing training. After implementation, the company continues its support with proof-of-concept guidance, billing services, and support for denied claims, along with charity care services. This holistic approach ensures that providers are well-equipped to give the best possible care.
Meet BioLab at Industry Events
For those interested in exploring BioLab Sciences' offerings, representatives will be present at the Symposium on Advanced Wound Care, where they will provide insights about their latest innovations. Attendees can find them at booth 245 during the event, reinforcing their commitment to engage with the wound care community.
About BioLab Holdings, Inc.
BioLab Holdings, Inc. is a renowned medical manufacturer headquartered in Phoenix, focusing on advancing wound healing products. The company’s product line includes the Membrane Wrap Lite™, Tri-Membrane Wrap™, Membrane Wrap™, and Membrane Wrap - Hydro™, all derived from human tissue allograft from amniotic membrane. These products maintain the essential properties of natural tissue while supporting optimal recovery for patients. BioLab is committed to innovation, quality, and superior customer service, ensuring that providers can successfully enhance their practices.
Media contact: Kwyn Lowe
Frequently Asked Questions
What is the Tri-Membrane Wrap?
The Tri-Membrane Wrap is an innovative amniotic skin substitute designed to protect deep wounds and poorly located areas through its triple-layered construction.
Who developed the Tri-Membrane Wrap?
This product was launched by BioLab Holdings, Inc., specifically under its brand BioLab Sciences.
How does the Tri-Membrane Wrap differ from other skin substitutes?
Its unique triple-layer design enhances thickness and strength, allowing for suturing and compatibility with wound VAC systems for larger wounds.
Is the Tri-Membrane Wrap FDA approved?
Yes, it is registered with the Tissue Reference Group and has a dedicated HCPCS code, ensuring its adherence to regulatory standards.
What support does BioLab provide for healthcare providers?
BioLab offers comprehensive training, product protocols, billing guidance, and ongoing support throughout the wound care process.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Plains All American Pipeline Unveils Q3 2024 Distributions
- Legal Action Looms for Paragon 28, Inc. Investors Amidst Claims
- Quantum Computing Inc.'s Q2 2024 Financial Results Overview
- Key Outcomes from MicroCloud Hologram Inc.'s AGM and Future Steps
- Quantum Computing Inc. Strengthens Market Position in 2024
- EQB Inc. Completes Redemption of Series 3 Preferred Shares
- Spero Therapeutics Unveils Positive Results for SPR720 Drug Trials
- 1st Health Inc. Expands Care Services with New Offices
- P10, Inc. Secures $65 Million for Community Developments
- Comstock Inc. Unveils Insights from 3Q24 Stakeholder Analysis
Recent Articles
- Topsail Steamer Unveils New Location in Gulf Shores
- Grant Challenge Celebrates Nonprofits with $3 Million Funding
- Exciting Premiere of Newark Fashion Forward on Digital Media
- Scotiabank Upgrades Capstone Copper Target to C$13 Amid Growth
- Scotiabank Holds Sector Perform Rating for CCU Amid Challenges
- Scotiabank Upgrades Dream Industrial’s Outlook for Growth
- Scotiabank Rethinks NorthWest Healthcare's Debt Management Strategy
- The Dixie Group's Transition to OTCQB and Financial Update
- OFS Credit Company Preferred Reaches New Heights in Trading
- Cathie Wood's Bold Predictions on AI and Bitcoin's Future
- Investigation into Smartsheet Sale Unveils Shareholder Rights
- Impact of U.S. Port Strikes on the Beef Supply Chain
- Recent Bitcoin Whale Activity Amid Geopolitical Concerns
- Bipartisan Support Emerges for Florida's Cannabis Reform Efforts
- Costco Expands Precious Metals Offerings with Platinum Bars
- Light & Wonder Faces Major Setback After Court's Verdict
- Rocket Lab's Share Surge: Key Developments Behind the Rise
- Fentress Architects Welcomes Back Renowned Designer Robin Ault
- Investigation News: Class Action Against Paragon 28, Inc. Stirs Interest
- Fentress Architects Announces Robin Ault's Return as Design Leader
- Insights into Etsy's Emerging Options Dynamics and Trends
- Alpha Pro Tech Expands Share Repurchase Program by $1 Million
- Understanding the Recent Trading Dynamics of T-Mobile US
- Nokia Resumes Share Repurchase Program, Boosting Investor Confidence
- Investors Anticipate Significant Moves for Wells Fargo
- Rich Eisen Podcast Network Welcomes Exciting New Shows
- Exploring the Growth Potential of Q2 Holdings in Digital Banking
- Revolutionizing Energy: Coates International Unveils Hydrogen Reactor
- Explore the Luxurious All-Electric Nest House for Sale
- Market Dynamics: Humana's $225 Support Level Analysis
- AIHA Takes Action for Hurricane Helene Relief Efforts
- How Nucor's Investment Growth Excels Over Five Years
- Iberdrola Honors Global Volunteers Making A Difference Today
- Exploring SIGA Technologies' Recent Turmoil and Its Impact
- Understanding Legal Options for Paragon 28, Inc. Investors
- Circle Joins U.S. Initiative to Fight Against Illicit Financing
- Viking Therapeutics Eyes Growth: Potential for Weight Loss Drug
- TD Cowen Maintains Strong Buy Rating on Establishment Labs
- Recursion Pharmaceuticals Sees Opportunity Post FDA Approval
- Teamsters Strike at Cargill: Workers Demand Fair Wages
- KeyBanc Increases Wabtec Target Price on Strong Growth Outlook
- Merrill Technologies Group Earns Recognition in M&A Awards
- Shotspotter Inc Faces Stock Challenges Amid Financial Struggles
- Jones Walker Enhances Legal Expertise with New Partners
- Digital Brands Group Faces Challenges Amid Stock Price Decline
- Power Drives Innovation in Patient Recruitment for Clinical Trials
- Badger Meter's Stock Hits Record High – What You Need to Know
- October: A Month to Prioritize Hearing Health Awareness
- 1847 Holdings LLC Experiences 52-Week Low in Stock Prices
- Doctor's Best Introduces New Citicoline Supplement for Brain Health